The role of insulin in the regulation of adipose tissue lipoprotein lipase activity in humans was investigated in 11 normal subjects and compared with the effects of 0.9% saline infusions in five control subjects. After a basal adipose tissue biopsy for lipoprotein lipase activity, insulin was rapidly infused to achieve and maintain serum levels of approximately 70 microunits/ml while plasma glucose was kept at basal concentrations. Free fatty acids in serum fell to 27 +/-3% of basal by 20 min (t = 5.19, P less than 0.001) and triglycerides decreased to 77 +/-3% of basal by 80 min (t = 3.76, P less than 0.01). Adipose tissue lipoprotein lipase activity failed to increase significantly above that measured in controls by the first 3 h of the study. By 6 h of the infusion a stimulatory effect of insulin on adipose tissue lipoprotein lipase was found (t = 3.94, P less than 0.01). There was no relationship between the amount of glucose infused and the insulin effect on the enzyme. The increase in adipose tissue lipoprotein lipase activity at 6 h, however, was inversely related to the basal lipase activity (r = -0.690, P less than 0.02). 
. Thus far, the hormonal regulation of ATLPL has not been clarified. In both, rat adipose tissue (4) and cultured preadipocytes (5, 6) , in vitro studies have demonstrated a stimulatory effect of insulin on ATLPL. Likewise, administration of glucose and/or insulin to experimental animals has resulted in an increase in the adipose tissue enzyme activity (7, 8) . For instance, Borensztajn et al. (7) have shown that glucose administration increased ATLPL levels, an effect attributed to postprandial hyperinsulinemia. To test the role of insulin, they injected the hormone intraperitoneally into starved rats, producing a fivefold increase in enzyme activity by 3 h. The authors were, however, unable to distinguish a primary effect of insulin from other effects associated with insulin-mediated glucose metabolism.
In humans, there is more than a suggestive role of an insulin-stimulatory effect on the enzyme. Type I diabetic patients with poor glucose control have depressed levels of ATLPL and postheparin plasma lipoprotein lipase activity (9) . With chronic administration of insulin and adequate glycemic control (9), enzyme activity in type I diabetics is normal (9, 10) . Type II diabetics also have lower ATLPL during periods of suboptimal glucose control (11, 12) . Pykalist6 et al. (11) found that the heparin-releasable (presumably functionally available) ATLPL activity, which was significantly lower in untreated type II diabetics than in controls, did not significantly change in patients after 1 wk of either insulin or chlorpropamide therapy, despite an improvement in glucose tolerance. ATLPL significantly rose, however, after those same diabetics were treated for 10 to 12 wk. In contrast, in hypertriglyceridemic, obese diabetics, Taylor et al. (12) have shown that 1 wk of insulin therapy increased the extracted form (presumably total adipose tissue enzyme) of ATLPL, which reached levels comparable to those found in control subjects.
Feeding in humans has resulted in higher ATLPL levels when compared with the fasting state (13, 14) , a change that has been thought to be secondary to rises in insulin levels. Additional support for this was a greater increase in ATLPL after formula containing 85% carbohydrate than after formula containing 45% fat (11) . These studies, however, have not been controlled for other variables, such as gut hormone responses to feeding and changes in glucose levels, which cloud the issue of the exact role of insulin regulation of ATLPL. In addition, there has been variability in the time of stimulatory response of ATLPL after feeding, from 60 min (13) to 6 h (14). This delayed effect might indicate, as was suggested by Chen et al. (15) , that postprandial TG removal may occur through mechanisms other than ATLPL.
Because there has not yet been a satisfactory method to isolate the role of insulin from gut hormones that may be increased with eating, we therefore turned our attention to the euglycemic clamp technique (16) Total cholesterol was also measured enzymatically (21) with a coefficient of variation of 2%.
High density lipoprotein (HDL) cholesterol was measured in plasma from which very low density lipoproteins and low density lipoproteins were precipitated by 4% sodium phosphotungstate (22 (23) .
FFA were determined by use of 60CO as a tracer, which formed a salt complex with available FFA (24) .
Catecholamines were determined by radiometric assay, CAT-A-KIT (Upjohn Co., Kalamazoo, MI), a modification of the method described by Passon and Peuler (25) .
The measurement of ATLPL in human adipose tissue was performed in tissue pieces of 40-50 mg and modified from the method previously described by Pykilisto et al. (11) 
RESULTS
Base-line and euglycemic clamp data. The baseline data of both the 11 study and 5 control subjects are displayed in Table I (Table I) . Base-line serum insulin concentrations on the day of the study ranged from 1 to 18 uU/ml, with the exception of one subject who had a level of 37 usU/ml (Table I) . A previously obtained insulin concentration (1 mo earlier) was < 2 1U/ml on this subject.
Catecholamines. There was no statistical difference between either the basal catecholamine levels (Table I) or the percentage change from basal between the two groups. Fig. 1 illustrates the changes in norepinephrine and epinephrine during the study. At all time points there was no statistically significant difference between the two populations. However, the insulin group showed a significant increase in norepinephrine over the study period (r = 0.294, n = 86 measurements, P < 0.01).
FFA. Insulin had a dramatic effect on lipolysis ( Fig. 2A) . FFA fell significantly within 20 min of the insulin infusion, from 323±50 to 81±14 nmol/ml, or 27±3.3% of basal. This change was statistically dif- In subsequent studies, biopsies were performed at an earlier timepoint (20 min) and at a later timepoint (180 min) to examine the possibility of a rapid or delayed response which might have been missed at 80 min. At 20 min, no effect was found, but at 180 min into the insulin infusion, insulin increased ATLPL above basal values in eight of the 11 subjects. The infusion was continued for another 3 h, at which time all subjects increased above basal. When compared with saline controls, a significant stimulatory response was found (t = 3.94, P < 0.01). ferent from that of the control group (t = 5.19, P < 0.001). Further suppression of lipolysis was soon after obtained, and FFA levels were maintained at the consistently low range for the remainder of the infusion. The control group, however, demonstrated a rise in FFA during the saline infusion.
TG. Similarly, insulin decreased TG concentrations (Fig. 2B) . TG levels did not change significantly for the first 60 min of the insulin infusion; however, by 80 min, levels fell to 77±3.1% of base line (t = 3.76, P <0.01) when compared with the saline infusion group. This trend continued during the remainder of the infusion. This effect appeared to follow the fall in FFA and was weakly but not significantly inversely related to the insulin effect on ATLPL at 6 h. Total cholesterol and HDL cholesterol. Total cholesterol and HDL cholesterol were compared before, during, and at the end of the insulin infusion. By the end of the infusion, the total cholesterol decreased from 159±5.3 to 138±4.3 mg/dl, whereas the HDL cholesterol fell less, from 54±4.0 to 50±4.4 mg/dl. Although there was an insignificant trend present between the insulin response of ATLPL and the basal activity at 3 h (r = -0.423), the 6-h insulin-mediated response was significantly dependent on the basal enzyme activity (r =-0.690, P < 0.02) (Fig. 4) (27) and suppression of very low density lipoprotein production rate, which is mediated by the decrease in FFA presented to the liver for very low density lipoprotein synthesis (28) . Further evidence that several factors may control this insulin-mediated fall in TG is the lack of a significant correlation between the fall in TG and the increase in ATLPL in the present study. The effects of stress from the adipose tissue biopsies were monitored by determinations of catecholamines before and throughout the infusions. Although variations in basal levels were wide among individuals, no significant differences were found between the control and study groups. There was also no relationship between basal or changes in catecholamines and the ATLPL response to insulin. There was, however, an upward trend in norepinephrine levels during insulin administration, a stimulatory response described previously at higher insulin concentrations over shorter time intervals by others (29) .
Insulin has a definite, but delayed, effect on ATLPL, with a significant rise in enzymatic activity occurring by 6 h when compared with controls infused with saline. Although the insulin stimulatory effect demonstrated in rat ATLPL occurred during variations in plasma glucose concentrations (7), the present investigation removes alterations in plasma glucose as a possible variable.
Although there was no relationship between the amount of glucose infused and the ATLPL response to insulin, it is impossible to conclude that insulinmediated effects on glucose metabolism have no relationship to the ATLPL response. Glucose utilization can only be approximated by the amount of glucose infused because hepatic glucose output was not measured. However, studies by Kolterman et al.2 indicate that total suppression of hepatic glucose output occurs by 45 min at similar insulin concentrations. Over a 6-h insulin infusion the amount of glucose infused is a reasonable estimate of glucose utilization. It would therefore appear that the effect of insulin on ATLPL is largely independent of insulin-mediated glucose metabolism.
In feeding studies, Goldberg et al. (14) showed that the basal level of ATLPL played a major role in subsequent elevations in enzyme activity. Similarly, the magnitude of the stimulatory effect of insulin on ATLPL in the present euglycemic clamp study proves to be a function of the basal enzyme activity. Interestingly, the control group had a significantly lower basal ATLPL than the study group (t = 2.34, P < 0.05). If the insulin effect on ATLPL were simply secondary to the intravenous fluid administration, the inverse relationship of basal ATLPL to the subsequent change in ATLPL would predict that the control group would have the greater response. In fact, as shown in Fig. 3 , an essentially flat response occurred, which provides further evidence that insulin was responsible for the stimulatory response.
Because feeding is not part of the protocol, the present study cannot address the question of the role of insulin-stimulated ATLPL in chylomicron removal. It may be that an insulin infusion in the presence of fat feeding may lead to an earlier and more pronounced increase in ATLPL.
The phenomenon of basal ATLPL determining the absolute change in subsequent stimulated enzyme activity is intriguing. To speculate, the primary regulatory mechanism of TG removal may be the adipose tissue or adipocyte itself. With high basal activity, adipose tissue is little affected by various stimuli, e.g., insulin administration or oral feedings. With a lower basal level, however, ATLPL responds more to extraadipose regulatory mechanisms, which may eventually prove to be nothing more than secondary factors in ATLPL control.
The euglycemic clamp technique is a tool that can be adapted to the study of lipid metabolism. A stimulatory role of insulin on ATLPL in humans, independent of enteric factors and possibly glucose metabolism, has now been provided. The interaction of other variables which may determine or augment the ATLPL response to insulin, e.g., oral fat, can now be systematically approached.
